Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124667324 | 12466732 | 4 | F | 20151118 | 20160815 | 20160615 | 20160826 | EXP | GB-AUROBINDO-AUR-APL-2016-07447 | AUROBINDO | 0.00 | M | Y | 97.00000 | KG | 20160826 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124667324 | 12466732 | 1 | PS | Losartan film-coated tablets | LOSARTAN | 1 | Oral | 100 MG, ONCE A DAY | Y | U | 90083 | 100 | MG | FILM-COATED TABLET | QD | ||||
| 124667324 | 12466732 | 2 | SS | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | UNK | 100 | MG | Y | Y | K019786 | 0 | TABLET | ||||
| 124667324 | 12466732 | 3 | SS | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, QD | 100 | MG | Y | Y | K019786 | 0 | 100 | MG | TABLET | QD | |
| 124667324 | 12466732 | 4 | SS | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | UNK | 100 | MG | Y | Y | K019786 | 0 | TABLET | ||||
| 124667324 | 12466732 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, DAILY | 245.104166 | MG | U | 0 | 2.5 | MG | QD | ||||
| 124667324 | 12466732 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 5 MG, DAILY | 19255.2083 | MG | U | 0 | 5 | MG | QD | ||||
| 124667324 | 12466732 | 7 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | Unknown | 2.5 MG, DAILY | 10740 | MG | U | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124667324 | 12466732 | 1 | Hypertension |
| 124667324 | 12466732 | 2 | Hypertension |
| 124667324 | 12466732 | 5 | Atrial fibrillation |
| 124667324 | 12466732 | 6 | Hypertension |
| 124667324 | 12466732 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124667324 | 12466732 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124667324 | 12466732 | Bradycardia | |
| 124667324 | 12466732 | Cardiac flutter | |
| 124667324 | 12466732 | Drug hypersensitivity | |
| 124667324 | 12466732 | Drug intolerance | |
| 124667324 | 12466732 | Dyschromatopsia | |
| 124667324 | 12466732 | Feeling abnormal | |
| 124667324 | 12466732 | Headache | |
| 124667324 | 12466732 | Palpitations | |
| 124667324 | 12466732 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124667324 | 12466732 | 3 | 20151118 | 20151125 | 0 | |
| 124667324 | 12466732 | 5 | 20150812 | 0 | ||
| 124667324 | 12466732 | 6 | 20050503 | 0 | ||
| 124667324 | 12466732 | 7 | 20040213 | 0 |